Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 2
2020 1
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Pneumatocoeles after bronchoscopic lung volume reduction with valves.
Lestelle F, Fumat R, Didier A, Collot S, Egenod T, Faviez G, Hermant C, Plat G, Guibert N. Lestelle F, et al. Among authors: egenod t. ERJ Open Res. 2021 Apr 6;7(2):00747-2020. doi: 10.1183/23120541.00747-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33834053 Free PMC article.
Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax Risk.
Egenod T, Tricard J, Fumat R, Simonneau Y, Favard F, Guillot MS, Collot S, Dupuis M, Melloni B, Vergnenegre A, Guibert N, Dusselier M. Egenod T, et al. Int J Chron Obstruct Pulmon Dis. 2021 Jun 28;16:1957-1965. doi: 10.2147/COPD.S307829. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34234426 Free PMC article.
Bilateral endobronchial valves treatment for severe emphysema.
Guibert N, Fumat R, Dupuis M, Dusselier M, Favard F, Heluain V, Mallah S, Barthes R, Simonneau Y, Egenod T. Guibert N, et al. Among authors: egenod t. ERJ Open Res. 2022 Apr 11;8(2):00672-2021. doi: 10.1183/23120541.00672-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35415190 Free PMC article.
[The rise of interventional pulmonology: A special issue coordinated by the GETIF].
Guibert N, Dutau H, Escarguel B, Egenod T, Fournier C, Legodec J, Trosini-Desert V, Lorut C, Lachkar S, Vergnon JM. Guibert N, et al. Among authors: egenod t. Rev Mal Respir. 2022 May;39(5):409-410. doi: 10.1016/j.rmr.2022.04.001. Epub 2022 May 12. Rev Mal Respir. 2022. PMID: 35570032 French. No abstract available.
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study.
Barlesi F, Dixmier A, Debieuvre D, Raspaud C, Auliac JB, Benoit N, Bombaron P, Moro-Sibilot D, Audigier-Valette C, Asselain B, Egenod T, Rabeau A, Fayette J, Sanchez ML, Labourey JL, Westeel V, Lamoureux P, Cotte FE, Allan V, Daumont M, Dumanoir J, Reynaud D, Calvet CY, Ozan N, Pérol M. Barlesi F, et al. Among authors: egenod t. Oncoimmunology. 2020 Apr 12;9(1):1744898. doi: 10.1080/2162402X.2020.1744898. Oncoimmunology. 2020. PMID: 33457089 Free PMC article. Clinical Trial.
Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers.
Dusselier M, Deluche E, Delacourt N, Ballouhey J, Egenod T, Melloni B, Vergnenègre C, Veillon R, Vergnenègre A. Dusselier M, et al. Among authors: egenod t. PLoS One. 2019 Jul 17;14(7):e0219060. doi: 10.1371/journal.pone.0219060. eCollection 2019. PLoS One. 2019. PMID: 31314761 Free PMC article.
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study.
Girard N, Galland-Girodet S, Avrillon V, Besse B, Duruisseaux M, Cadranel J, Otto J, Prevost A, Roch B, Bennouna J, Bouledrak K, Coudurier M, Egenod T, Lamy R, Ricordel C, Moro-Sibilot D, Odier L, Tillon-Strozyk J, Zalcman G, Missy P, Westeel V, Baldacci S. Girard N, et al. Among authors: egenod t. ESMO Open. 2022 Apr;7(2):100418. doi: 10.1016/j.esmoop.2022.100418. Epub 2022 Feb 26. ESMO Open. 2022. PMID: 35227966 Free PMC article.
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting.
Sassier M, Dugué AE, Clarisse B, Lesueur P, Avrillon V, Bizieux-Thaminy A, Auliac JB, Kaluzinski L, Tillon J, Robinet G, Le Caer H, Monnet I, Madroszyk A, Boza G, Falchero L, Fournel P, Egenod T, Toffart AC, Leiber N, Do P, Gervais R. Sassier M, et al. Among authors: egenod t. Lung Cancer. 2015 Aug;89(2):161-6. doi: 10.1016/j.lungcan.2015.05.005. Epub 2015 May 15. Lung Cancer. 2015. PMID: 26037036